Загрузка...
Cancer Immunotherapy Using Checkpoint Blockade
The release of negative regulators of immune activation (immune checkpoints) that limit antitumor responses has resulted in unprecedented rates of long-lasting tumor responses in patients with a variety of cancers. This can be achieved by antibodies blocking the cytotoxic T lymphocyte antigen-4 (CTL...
Сохранить в:
| Опубликовано в: : | Science |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7391259/ https://ncbi.nlm.nih.gov/pubmed/29567705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.aar4060 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|